Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
There are currently no FDA-approved therapeutics available to treat Rift Valley fever virus (RVFV) infection. In an effort to repurpose drugs for RVFV treatment, a library of FDA-approved drugs was screened to determine their ability to inhibit RVFV. Several drugs from varying compound classes, incl...
Main Authors: | Benedict, Ashwini, Bansal, Neha, Senina, Svetlana, Hooper, Idris, Lundberg, Lindsay, de la Fuente, Cynthia, Narayanan, Aarthi, Gutting, Bradford, Kehn-Hall, Kylene |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495339/ |
Similar Items
-
Repurposing FDA-approved drugs for anti-aging therapies
by: Snell, Terry W., et al.
Published: (2016) -
The Use of Nanotrap Particles in the Enhanced Detection of Rift Valley Fever Virus Nucleoprotein
by: Shafagati, Nazly, et al.
Published: (2015) -
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
by: Kim, Kevin, et al.
Published: (2015) -
Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?
by: Zaidi, Asifa, et al.
Published: (2015) -
Repurposing of FDA-approved drugs against cancer – focus on metastasis
by: Ozsvári, Béla, et al.
Published: (2016)